Author

M. Konings

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

W. Lim· 2 shared W. Van de Sande· 2 shared A. H. Fahal· 1 shared A. Hasegawa· 1 shared A. Verbon· 1 shared B. Laleu· 1 shared B. Perry· 1 shared C. Takahashi· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

W. Lim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella

I. Abugessaisa, M. Konings, R.-I. Manabe, T. Kawashima, A. Hasegawa, C. Takahashi, M. Tagami, Y. Okazaki, W. Lim, A. Verbon, A. H. Fahal, T. Kasukawa, W. Van de Sande

This study identifies iron regulatory pathways involved in Madurella mycetomatis grain formation in Galleria mellonella using time-course transcriptomic profiling.

bioRxiv · Dec 20, 2022 · PreprintMicrobiology

Addressing the Most Neglected Diseases through an Open Research Model: the Discovery of Fenarimols as Novel Drug Candidates for Eumycetoma

W. Lim, Y. Melse, M. Konings, H. P. Duong, K. Eadie, B. Laleu, B. Perry, M. Todd, J.-R. Ioset, W. van de Sande

This paper identifies new drug candidates for eumycetoma by screening 800 compounds and testing their in vitro and in vivo activity against Madurella mycetomatis, using an open-source approach to accelerate drug discovery.

bioRxiv · Feb 2, 2018Pharmacology & Toxicology